Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of clinical features of cystic fibrosis patients eligible but not on CFTR modulators to ineligible for CFTR modulators.
Nayır Büyükşahin H, Emiralioğlu N, Yalçın E, Şen V, Selimoğlu Şen H, Arslan H, Başkan AK, Çakır FB, Koray CF, Yılmaz Aİ, Ercan F, Altıntaş DU, Serbes M, Keskin Ö, Arık E, Gülen F, Barlık M, Karcıoğlu O, Damadoğlu E, Köse M, Ersoy A, Bingöl A, Başaran E, Çakır EP, Aslan AT, Canıtez Y, Korkmaz M, Özdemir A, Harmancı K, Soydaş ŞS, Hangül M, Yüksel H, Özcan G, Korkmaz P, Kılıç M, Gayretli Aydın ZG, Çaltepe G, Can D, Doğru S, Kartal Öztürk G, Süleyman A, Topal E, Özsezen B, Hızal M, Demirdöğen E, Ogun H, Börekçi Ş, Yazan H, Çakır E, Şişmanlar Eyüboğlu T, Çobanoğlu N, Cinel G, Pekcan S, Özçelik U, Doğru D. Nayır Büyükşahin H, et al. Pediatr Pulmonol. 2024 May 21. doi: 10.1002/ppul.27051. Online ahead of print. Pediatr Pulmonol. 2024. PMID: 38771207
Impact of interruption of CFTR modulator therapies.
Capraz Yavuz B, Yalcin E, Nayir Buyuksahin H, Sunman B, Guzelkas I, Alboga D, Akgul Erdal M, Demir HI, Atan R, Emiralioglu N, Dogru D, Ozcelik U, Kiper N. Capraz Yavuz B, et al. Among authors: nayir buyuksahin h. J Cyst Fibros. 2024 May 18:S1569-1993(24)00069-9. doi: 10.1016/j.jcf.2024.05.006. Online ahead of print. J Cyst Fibros. 2024. PMID: 38762388
Galectin-3 levels in children with cystic fibrosis.
Ademhan Tural D, Emiralioglu N, Akin S, Alboga D, Ozsezen B, Nayir Buyuksahin H, Guzelkas I, Kasikci M, Sunman B, Gungor I, Yalcin E, Dogru D, Kiper N, Demirel AH, Ozcelik U. Ademhan Tural D, et al. Among authors: nayir buyuksahin h. Eur J Pediatr. 2024 May;183(5):2333-2342. doi: 10.1007/s00431-024-05479-6. Epub 2024 Mar 2. Eur J Pediatr. 2024. PMID: 38430280
Successful atorvastatin treatment of pulmonary alveolar proteinosis in a child with GM-CSF receptor deficiency.
Nayır Büyükşahin H, Yalçın E, Özdemir A, Haliloglu M, Orhan D, Griese M, Gothe F, Rapp C, Hardenberg SGV, Debbağ S, Güzelkaş İ, Emiralioğlu N, Doğru D, Özçelik U, Kiper N. Nayır Büyükşahin H, et al. Pediatr Pulmonol. 2024 Jun;59(6):1777-1780. doi: 10.1002/ppul.26946. Epub 2024 Feb 27. Pediatr Pulmonol. 2024. PMID: 38411295 No abstract available.
ERS International Congress 2023: highlights from the Paediatrics Assembly.
Vijverberg SJH, Kampouras A, Nayir Büyükşahin H, Makrinioti H, Petrarca L, Schmidt M, Schreck LD, Urbantat RM, Beydon N, Goutaki M, Lavizzari A, Proesmans M, Schramm D, Stahl M, Zacharasiewicz A, Moeller A, Pijnenburg MW. Vijverberg SJH, et al. Among authors: nayir buyuksahin h. ERJ Open Res. 2024 Feb 26;10(1):00853-2023. doi: 10.1183/23120541.00853-2023. eCollection 2024 Jan. ERJ Open Res. 2024. PMID: 38410713 Free PMC article.
The airway microbiota in siblings with primary ciliary dyskinesia: Related factors and correlation with clinical characteristics.
Ademhan Tural D, Kasikci M, Eryilmaz Polat S, Ozsezen B, Hizal M, Sunman B, Nayir Büyüksahin H, Guzelkas I, Altay O, Dolgun TY, Emiralioglu N, Yalcin E, Dogru D, Kiper N, Hascelik G, Diker KS, Ozcelik U. Ademhan Tural D, et al. Among authors: nayir buyuksahin h. Pediatr Pulmonol. 2024 Mar;59(3):695-706. doi: 10.1002/ppul.26816. Epub 2023 Dec 13. Pediatr Pulmonol. 2024. PMID: 38088243
Childhood interstitial lung disease in Turkey: first data from the national registry.
Nayır-Büyükşahin H, Emiralioğlu N, Kılınç AA, Girit S, Yalçın E, Şişmanlar Eyüboğlu T, Çobanoğlu N, Cinel G, Pekcan S, Gökdemir Y, Oğuz B, Orhan D, Doğru D, Özçelik U, Başkan AK, Arslan H, Çokuğraş H, Onay ZR, Oksay SC, Tortop DM, Aslan AT, Kekeç H, Zirek F, Tekin MN, Gülen F, Girgin Dindar B, Eryılmaz Polat S, Uytun S, Yılmaz Aİ, Ünal G, Eralp EE, Karadağ B, Hangül M, Köse M, Özsezen B, Çakır E, Bingöl A, Hızal M, Kartal Öztürk G, Uyan ZS, Ramaslı Gürsoy T, Serbes M, Kiper N. Nayır-Büyükşahin H, et al. Eur J Pediatr. 2024 Jan;183(1):295-304. doi: 10.1007/s00431-023-05290-9. Epub 2023 Oct 25. Eur J Pediatr. 2024. PMID: 37875631
Reply - Letter to the editor (YCLNU-D-23-01653).
Nayir Buyuksahin H, Dogru D, Ozon A. Nayir Buyuksahin H, et al. Clin Nutr. 2023 Nov;42(11):2284-2285. doi: 10.1016/j.clnu.2023.09.015. Epub 2023 Sep 28. Clin Nutr. 2023. PMID: 37798225 No abstract available.
Cystic fibrosis related bone disease in children: Can it be predicted?
Nayir Buyuksahin H, Dogru D, Gözmen O, Ozon A, Portakal O, Emiralioglu N, Haliloglu M, Kılıc K, Vardar Yaglı N, Yıldırım D, Dag O, Guzelkas I, Yalcın E, Ozcelik U, Kiper N. Nayir Buyuksahin H, et al. Clin Nutr. 2023 Sep;42(9):1631-1636. doi: 10.1016/j.clnu.2023.07.015. Epub 2023 Jul 17. Clin Nutr. 2023. PMID: 37487275
28 results